Therefore in this study, we investigated the potency of insoluble tau from human AD to induce tau pathology in well-characterized transgenic rat models of tauopathy expressing human truncated tau aa151–391 in two different genetic backgrounds (Zilka et al., 2006; Koson et al., 2008). The gene discussed is MAPT; the disease is Alzheimer disease.